Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
471 participants
INTERVENTIONAL
2008-01-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STAGE-12
STAGE-12 received 3 individual and 5 group 12-step facilitation sessions focusing on 12-step principles plus an intensive referral in which counselors linked participants to community-based 12-step volunteers. These sessions took the place of 3 individual and 5 group sessions in the standard intensive outpatient drug treatment program and were integrated into treatment as usual.
STAGE-12
The STAGE-12 intervention will consist of a combination of five group and three individual sessions. The five group sessions will be taken from the Project MATCH Twelve Step Facilitation manual as modified for use with drug abusers and adapted for delivery in a group format. The group sessions will be augmented by three individual sessions derived from the introductory and termination sessions from the TSF manual and incorporating elements of the brief intensive 12-step referral procedure.
Treatment as Usual
Treatment as usual received standard care provided in intensive outpatient drug treatment program without the STAGE-12 components.
Treatment as Usual
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
STAGE-12
The STAGE-12 intervention will consist of a combination of five group and three individual sessions. The five group sessions will be taken from the Project MATCH Twelve Step Facilitation manual as modified for use with drug abusers and adapted for delivery in a group format. The group sessions will be augmented by three individual sessions derived from the introductory and termination sessions from the TSF manual and incorporating elements of the brief intensive 12-step referral procedure.
Treatment as Usual
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current diagnosis of stimulant abuse or dependence
* willing to participate in the protocol
Exclusion Criteria
* pending legal action that would inhibit their participation in the study
* in need of detoxification from opiates
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dennis Donovan
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dennis Donovan, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Dennis Daley, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Western Psychiatric Institute and Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gateway Community Services
Jacksonville, Florida, United States
Hina Mauka Kaneohe Rehabilitation Services
Kaneohe, Hawaii, United States
Maryhaven, Inc.
Columbus, Ohio, United States
Willamette Family Treatment Services
Eugene, Oregon, United States
ChangePoint, Inc.
Portland, Oregon, United States
Addiction Medicine Services (WPIC)
Pittsburgh, Pennsylvania, United States
Dorchester Alcohol and Drug Commission
Summerville, South Carolina, United States
Nexus Recovery Center
Dallas, Texas, United States
Evergreen Manor, Inc.
Everett, Washington, United States
Recovery Centers of King County
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, Doyle SR, Floyd AS, Knox PC, Botero C, Kelly TM, Killeen TK, Hayes C, Kau'i Baumhofer N, Seamans C, Zammarelli L. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013 Jan;44(1):103-14. doi: 10.1016/j.jsat.2012.04.004. Epub 2012 May 31.
Related Links
Access external resources that provide additional context or updates about the study.
Link to description of the STAGE-12 protocol on the NIDA Clinical Trials Network web site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CTN-0031
Identifier Type: -
Identifier Source: org_study_id